Citius Oncology, Inc.

Citius Oncology, Inc.

CTOR
Citius Oncology, Inc.US flagNASDAQ Global Market
0.57
USD
-0.12
- -
53.00MMarket Cap

Income Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
09/30/2022
09/30/2023
09/30/2024
09/30/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
5
12
21
24
+ Selling, General & Admin
1
8
16
17
+ Research & Development
3
4
5
6
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
-5
-12
-21
-24
- Non-Operating (Income) Loss
- -
- -
- -
- -
+ Interest Expense, Net
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
Pretax Income
-5
-12
-21
-24
- Income Tax Expense (Benefit)
1
1
1
1
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-5
-13
-21
-25
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-5
-13
-21
-25
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-5
-13
-21
-25
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-5
-13
-21
-25
EBIT
-5
-12
-21
-24
EBITDA
-5
-12
-21
-24
EBITDA Margin (%)
- -
- -
- -
- -
EBITA
-5
-12
-21
-24
Gross Margin (%)
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Basic Weighted Avg Shares
71
71
68
73
Basic EPS, GAAP
-0.08
-0.18
-0.31
-0.34
Basic EPS from Cont Ops
-0.08
-0.18
-0.31
-0.34
Diluted Weighted Avg Shares
71
71
68
73
Diluted EPS, GAAP
-0.08
-0.18
-0.31
-0.34
Diluted EPS from Cont Ops
-0.08
-0.18
-0.31
-0.34

Balance Sheet (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
09/30/2022
09/30/2023
09/30/2024
09/30/2025
Total Current Assets
3
8
11
28
+ Cash, Cash Equivalents & STI
- -
- -
- -
4
+ Cash & Cash Equivalents
- -
- -
- -
4
+ ST Investments
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
+ Inventories
- -
- -
8
22
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
2
12
+ Finished Goods
- -
- -
6
11
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
3
8
3
1
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
40
40
73
73
+ Property, Plant & Equip, Net
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
40
40
73
73
+ Total Intangible Assets
40
40
73
73
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
40
40
73
73
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
Total Assets
43
48
84
101
+ Payables & Accruals
6
21
33
49
+ Accounts Payable
- -
1
4
13
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
6
20
29
36
+ ST Debt
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
Total Current Liabilities
6
21
33
49
+ LT Debt
- -
- -
4
4
+ LT Borrowings
- -
- -
4
4
+ LT Finance Leases
- -
- -
- -
- -
+ Other LT Liabilities
1
1
2
3
+ Accrued Liabilities
1
1
2
3
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
Total Noncurrent Liabilities
1
1
6
7
Total Liabilities
6
22
38
56
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
42
44
85
109
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
42
44
85
109
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-5
-18
-39
-64
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
36
26
46
45
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
36
26
46
45
Total Liabilities & Equity
43
48
84
101
Shares Outstanding
71
71
72
84
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
Net Debt
- -
- -
4
- -
Net Debt to Equity
- -
- -
8.24
-0.28
Tangible Common Equity Ratio
-138.75
-187
-248.52
-103.6
Current Ratio
0.46
0.37
0.34
0.56
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
09/30/2022
09/30/2023
09/30/2024
09/30/2025
+ Net Income
-5
-13
-21
-25
+ Depreciation & Amortization
- -
- -
- -
- -
+ Non-Cash Items
1
3
8
9
+ Stock-Based Compensation
- -
2
7
8
+ Deferred Income Taxes
1
1
1
1
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
- -
+ Chg in Non-Cash Work Cap
5
10
13
10
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
-2
-13
+ (Inc) Dec in Prepaid Assets
-1
-5
-1
- -
+ Inc (Dec) in Accts Payable
6
15
16
23
+ Inc (Dec) in Other
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
- -
- -
- -
-5
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-5
-6
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
-5
-6
+ Cash (Repurchase) of Equity
- -
- -
- -
15
+ Increase in Capital Stock
- -
- -
- -
15
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-5
-6
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
4
- -
+ Cash From Debt
- -
- -
4
- -
+ Repayments of Debt
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
- -
- -
5
15
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
- -
- -
- -
4
EBITDA
-5
-12
-21
-24
EBITDA Margin (%)
- -
- -
- -
- -
Free Cash Flow
- -
- -
-5
-11
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
- -
4
-5
Free Cash Flow per Basic Share
- -
- -
-0.07
-0.15
Price/Free Cash Flow
- -
- -
18.45
576.59
Cash Flow to Net Income
- -
- -
-0.01
0.22
Capital Expenditures
- -
- -
-5
-6